论文部分内容阅读
目的观察地塞米松联合沐舒坦雾化吸入治疗矽肺合并肺部感染患者的临床效果。方法将医院就医的矽肺合并肺部感染患者中抽取58例作为研究对象,随机分为观察组和对照组,每组29例。观察组采用地塞米松与沐舒坦雾化吸入联合进行治疗,对照组则使用盐酸氨溴索进行治疗。治疗结束后,观察比较2组患者的临床疗效。结果观察组总有效率为96.55%,高于对照组的75.86%,差异有统计学意义(P<0.05)。结论矽肺合并肺部感染患者采用地塞米松联合沐舒坦雾化吸入进行治疗,效果显著,具有较高的医学推广意义。
Objective To observe the clinical effect of inhalation of dexamethasone combined with mucosolvan inhalation in patients with silicosis and pulmonary infection. Methods A total of 58 patients with silicosis and pulmonary infection admitted to the hospital were randomly divided into observation group and control group, with 29 cases in each group. The observation group was treated with inhalation of dexamethasone and mucosolvan, while the control group was treated with ambroxol hydrochloride. After treatment, the clinical efficacy of two groups were observed and compared. Results The total effective rate in the observation group was 96.55%, which was higher than that in the control group (75.86%), the difference was statistically significant (P <0.05). Conclusion The patients with silicosis and pulmonary infection treated with dexamethasone combined with mucosolvan inhalation are effective and have a good medical promotion.